Navy moves dengue fever vaccine into clinical trials – FierceVaccines

The study will involve 40 people who will receive the vaccine alone or with Vical’s Vaxfectin adjuvant. The tetravalent vaccine was developed and manufactured for the NMRC by Vical under a Collaborative Research and Development Agreement (CRADA), but Vical retains no rights to the vaccine.

via Navy moves dengue fever vaccine into clinical trials – FierceVaccines.

Advertisements


Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s